Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Deficit)

v3.7.0.1
Condensed Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Equity Payable [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Beginning balance, Amount at Dec. 31, 2015 $ 28,788 $ 100,862 $ 69,903,527   $ (65,159,010) $ 4,874,167
Beginning balance, Shares at Dec. 31, 2015 28,787,991          
Issuance of common stock for acquisition, Amount $ 1,015   709,485     710,500
Issuance of common stock for acquisition, Shares 1,015,000          
Issuance of common stock for financing, Amount $ 3,256   1,950,344     1,953,600
Issuance of common stock for financing, Shares 3,256,000          
Issuance of common stock for warrant conversion, Amount $ 3,330   2,535,858     2,539,188
Issuance of common stock for warrant conversion, Shares 3,329,990          
Stock based compensation, Amount     1,599,169     1,599,169
Foreign currency translation adjustment       $ (32,999)   (32,999)
Net loss         (9,514,461) (9,514,461)
Ending balance, Amount at Dec. 31, 2016 $ 36,389 100,862 76,698,383 (32,999) (74,673,471) 2,129,164
Ending balance, Shares at Dec. 31, 2016 36,388,981          
Stock based compensation, Amount     337,417     337,417
Foreign currency translation adjustment       (5,221)   (5,221)
Net loss         (1,349,226) (1,349,226)
Ending balance, Amount at Mar. 31, 2017 $ 36,389 $ 100,862 $ 77,035,800 $ (38,220) $ (76,022,697) $ 1,112,134
Ending balance, Shares at Mar. 31, 2017 36,388,981